| Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation JV Lee, A Carrer, S Shah, NW Snyder, S Wei, S Venneti, AJ Worth, ... Cell metabolism 20 (2), 306-319, 2014 | 537 | 2014 |
| Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer. EK Kulangara K1, Zhang N1, Corigliano E1, Guerrero L1, Waldroup S1, Jaiswal ... Arch Pathol Lab Med, 2018 | 460* | 2018 |
| Malic enzyme tracers reveal hypoxia-induced switch in adipocyte NADPH pathway usage L Liu, S Shah, J Fan, JO Park, KE Wellen, JD Rabinowitz Nature chemical biology 12 (5), 345-352, 2016 | 128 | 2016 |
| Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer YB Wetherill, JK Hess-Wilson, CES Comstock, SA Shah, CR Buncher, ... Molecular cancer therapeutics 5 (12), 3181-3190, 2006 | 87 | 2006 |
| Development of the combined positive score (CPS) for the evaluation of PD-L1 in solid tumors with the immunohistochemistry assay PD-L1 IHC 22C3 pharmDx. K Kulangara, DA Hanks, S Waldroup, L Peltz, S Shah, C Roach, JW Juco, ... Journal of Clinical Oncology 35 (15_suppl), e14589-e14589, 2017 | 79 | 2017 |
| Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism S Shah, WJ Carriveau, J Li, SL Campbell, PK Kopinski, HW Lim, N Daurio, ... Oncotarget 7 (28), 43713, 2016 | 69 | 2016 |
| Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression S Shah, S Prasad, KE Knudsen Cancer research 72 (5), 1248-1259, 2012 | 45 | 2012 |
| Obesity, cancer and acetyl-CoA metabolism JV Lee, SA Shah, KE Wellen Drug Discovery Today: Disease Mechanisms 10 (1-2), e55-e61, 2013 | 30 | 2013 |
| 2, 2-bis (4-chlorophenyl)-1, 1-dichloroethylene stimulates androgen independence in prostate cancer cells through combinatorial activation of mutant androgen receptor and … S Shah, JK Hess-Wilson, S Webb, H Daly, S Godoy-Tundidor, J Kim, ... Molecular Cancer Research 6 (9), 1507-1520, 2008 | 20 | 2008 |
| Young adult and parent stakeholder perspectives on participation in patient-centered comparative effectiveness research T Saunders, TI Mackie, S Shah, H Gooding, SD De Ferranti, LK Leslie Journal of Comparative Effectiveness Research 5 (5), 487-497, 2016 | 11 | 2016 |
| A cancerous web: signaling, metabolism, and the epigenome JV Lee, S Shah, A Carrer, KE Wellen Molecular & Cellular Oncology 2 (2), e965620, 2015 | 4 | 2015 |
| Abstract B40: Oncogenic Kras induces histone acetylation in pancreatic ductal adenocarcinoma A Carrer, JV Lee, S Shah, NW Snyder, E Jackson, NM Aiello, BA Garcia, ... Cancer Research 75 (13_Supplement), B40-B40, 2015 | 1 | 2015 |
| Quantification of NADPH balance during adipogenesis L Liu, S Shah, J Fan, K Wellen, J Rabinowitz Cancer & Metabolism 2, 1-1, 2014 | 1 | 2014 |
| Quantification of NADPH balance in cancer L Liu, L Chen, G Ducker, J Park, S Shah, KE Wellen, JD Rabinowitz Cancer Research 76 (14_Supplement), 1013-1013, 2016 | | 2016 |
| Abstract PR03: Exploring the link between Kras and histone acetylation A Carrer, JV Lee, S Shah, NM Aiello, NW Snyder, AJ Worth, IA Blair, ... Cancer Research 76 (2_Supplement), PR03-PR03, 2016 | | 2016 |
| Abstract A31: Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation S Shah, JV Lee, A Carrer, NW Snyder, KE Wellen Molecular Cancer Therapeutics 14 (7_Supplement), A31-A31, 2015 | | 2015 |
| Gene-environment interactions and novel therapeutic interventions in prostate cancer S Shah Thomas Jefferson University, 2012 | | 2012 |
| Muhammad Farooq Swati, PhD Department of Archaeology, University of Peshawar H Falk, S Mohanty, JF Bartolomeo, SAA Shah, T Roche, WA Shah, ... | | |
Alessandro CarrerGroup Leader, Veneto Institute of Molecular Medicine (VIMM)Verified email at vimm.it
